|
|
By mobstr, on March 29th, 2012
Highlights from recent Life Science venture capital news.
13.03.2012 – Cleaveland, OH
ViewRay Closes $45 million Round of Series C Financing
ViewRay™ Incorporated, a privately held medical device company, has closed the final tranche of a $45 million round of Series C venture capital financing. Institutional investors include Aisling Capital, Fidelity Biosciences, Kearny Venture Partners, OrbiMed Advisors and Siemens . . . → Read More: Life Science Venture Capital Investment News Round Up – 19 March 2012
By mobstr, on March 27th, 2012
Highlights from recent IT venture capital investment activity.
North America
First Venture Round
24.03.2012 – Los Angeles, CA
The Honest Company Completes $27M Series A Financing
The Honest Company, a Los Angeles, CA-based e-commerce site that offers non-toxic and natural baby and family products, has completed $27m Series A financing. Backers include General Catalyst, Lightspeed Venture Partners and . . . → Read More: IT Venture Capital Investment News Round Up – 27 March 2012
By mobstr, on March 26th, 2012
Highlights from recent Life Science venture capital news.
Secondary Venture Round
21.03.2012 – Redwood City, CA
Myoscience Closes $33 Million Series D Financing
Myoscience, Inc., a Redwood City, California-based medical device company, has closed a $33m Series D financing. Backers include existing investors Accuitive Medical Ventures, American Equities Overseas, DeNovo Ventures, Medicis Capital, Nexus Medical Partners, Saratoga Ventures, and Valiance. http://www.myoscience.com/sites/default/files/public/pdf/myoscience_seriesD_press%20release%20copy.pdf
. . . → Read More: Life Science Venture Capital Investment News Round Up – 26 March 2012
By mobstr, on March 20th, 2012
Highlights from recent IT venture capital investment activity.
15.03.2012 – Bellevue, WA
Apptio raises $50M in new funding
Apptio, moving further down the path toward a possible IPO, today announced a $50 million funding round led by T. Rowe Price — a significant injection of capital for the Seattle-area company and one of the largest venture capital financings in . . . → Read More: IT Venture Capital Investment News Round Up – 20 March 2012
By mobstr, on March 20th, 2012
Highlights from recent IT venture capital investment activity.
15.03.2012 – Bellevue, WA
Apptio raises $50M in new funding
Apptio, moving further down the path toward a possible IPO, today announced a $50 million funding round led by T. Rowe Price — a significant injection of capital for the Seattle-area company and one of the largest venture capital financings in . . . → Read More: IT Venture Capital Investment News Round Up – 20 March 2012
By mobstr, on March 19th, 2012
Highlights from recent Life Science venture capital news.
13.03.2012 – Cleaveland, OH
ViewRay Closes $45 million Round of Series C Financing
ViewRay™ Incorporated, a privately held medical device company, has closed the final tranche of a $45 million round of Series C venture capital financing. Institutional investors include Aisling Capital, Fidelity Biosciences, Kearny Venture Partners, OrbiMed Advisors and Siemens . . . → Read More: Life Science Venture Capital Investment News Round Up – 19 March 2012
By mobstr, on March 15th, 2012
A round up of deal activity in IT, Life Science, Med Tech & Biotech Venture Capital Investment over the past week.
Total No. Deals
NA
EU
Total Raised $
Total Raised €
64
50
14
430.4
327.0
North America
No. Deals
Total $
Total €
Average $
Average €
50
389.0
295.5
8.5
6.4
Europe
No. Deals
Total $
Total €
Average $
Average €
14
41.4
31.5
4.1
3.1
Breakdown By Sector
Life Sciences
No. Deals
NA
EU
Total $
Total €
18
14
4
243.9
185.3
Average Deal NA & EU
$
€
13.5
10.3
Largest Deals
Company Name
Region
Stage
$m
€m
Aragon Pharmaceuticals
NA
SVR
42.0
31.9
Phosphate Therapeutics
EU
FVR
13.8
10.5
TMT
No. Deals
NA
EU
Total $
Total €
46
10
36
186.5
141.6
Average . . . → Read More: Venture Capital Investment – 15 March 2011
By mobstr, on March 13th, 2012
Highlights from recent IT venture capital investment activity.
North America
First Venture Round
05.03.2012 – Los Angeles, CA
Nasty Gal Completes $9m Funding with Index Ventures
Nasty Gal, a Los Angeles, CA-based fashion retail website for girls, has completed a $9m minority investment with Index Ventures’ Growth Fund. The company intends to invest the capital in technology, operations, . . . → Read More: IT Venture Capital Investment News Round Up – 13 March 2012
By mobstr, on March 12th, 2012
Highlights from recent Life Science venture capital news.
First Venture Round
05.03.2012 – Medford, MA
4s3 Bioscience raises $20m
Boston-based biotechnology company 4s3 Bioscience, Inc., which develops genetic disease therapies for orphan neuromuscular disorders, including some forms of muscular dystrophy, has raised $20 million in financing from KLP Enterprises LLC, a family-owned trust that owns and manages a broad . . . → Read More: Life Science Venture Capital Investment News Round Up – 12 March 2012
By mobstr, on March 6th, 2012
Highlights from recent IT venture capital investment activity.
Early Stage Venture Capital Investments
27.02.2012 – Mountain View, CA
Game Closure Announces $12 Million in Series A Financing Led by Highland Capital Partners
Game Closure today announced a Series A financing round of $12 million to fund its advanced HTML5-based cross-platform game technology. The round was led by Highland Capital . . . → Read More: IT Venture Capital Investment News Round Up – 6 March 2012
|
|
Comments are closed 